Among 3 analysts covering Hugo Boss AG (OTCMKTS:BOSSY), 0 have Buy rating, 0 Sell and 3 Hold. Therefore 0 are positive. Hugo Boss AG had 4 analyst reports since October 20, 2016 according to SRatingsIntel. BNP Paribas upgraded HUGO BOSS AG SPON ADR EA REPR 1 5 ORD (OTCMKTS:BOSSY) on Thursday, October 20 to “Outperform” rating. Citigroup downgraded the stock to “Neutral” rating in Friday, January 13 report. The stock has “Neutral” rating by BNP Paribas on Thursday, February 9. The firm earned “Sector Perform” rating on Tuesday, February 21 by RBC Capital Markets. See HUGO BOSS AG SPON ADR EA REPR 1 5 ORD (OTCMKTS:BOSSY) latest ratings:
21/02/2017 Broker: RBC Capital Markets Old Rating: Underperform New Rating: Sector Perform Upgrade
09/02/2017 Broker: BNP Paribas Old Rating: Outperform New Rating: Neutral Downgrade
13/01/2017 Broker: Citigroup Old Rating: Buy New Rating: Neutral Downgrade
20/10/2016 Broker: BNP Paribas Old Rating: Neutral New Rating: Outperform Upgrade
The director of Female Health Co, Georges Makhoul is in the stock market news today. It was published in a public report filled by Georges Makhoul and submitted to the U.S. Security & Exchange Commission on March 21, 2017, he obtained 100,000 shares from the stock exchange listed company having a market value of $105,490 U.S. Dollars. The insider shares average price was $1.1. Currently, Georges Makhoul owns 189,444 shares which make up roughly 0.64% of the company’s total market capitalization.
The Female Health Company is a therapeutics firm focused on developing and commercializing pharmaceuticals and devices in men’s and women’s health and oncology. The company has market cap of $34.86 million. The Firm is engaged in the development, manufacture and marketing of consumer healthcare products. It currently has negative earnings. The Firm has three divisions: Pharmaceutical and Devices, Consumer Health Products and Public Sector.
The stock decreased 4.63% or $0.05 on March 21, reaching $1.03. About shares traded. Female Health Co (NASDAQ:FHCO) has declined 24.44% since August 15, 2016 and is downtrending. It has underperformed by 31.47% the S&P500.
Analysts await Female Health Co (NASDAQ:FHCO) to report earnings on April, 27.
Investors sentiment increased to 1.18 in 2016 Q4. Its up 0.65, from 0.53 in 2016Q3. It improved, as 5 investors sold Female Health Co shares while 6 reduced holdings. 5 funds opened positions while 8 raised stakes. 2.60 million shares or 9.07% more from 2.39 million shares in 2016Q3 were reported. Eqis Capital Mngmt Inc has invested 0% in Female Health Co (NASDAQ:FHCO). 11,019 were reported by Creative Planning. Commercial Bank Of Ny Mellon Corporation has invested 0% in Female Health Co (NASDAQ:FHCO). Wells Fargo Communications Mn holds 0% or 285,833 shares. 250 were reported by Deutsche Natl Bank Ag. Illinois-based Northern Trust Corporation has invested 0% in Female Health Co (NASDAQ:FHCO). California Employees Retirement System holds 0% or 98,400 shares in its portfolio. Blackrock Inv Management Ltd Liability Co accumulated 3,938 shares or 0% of the stock. 12,879 were accumulated by Ameriprise. Ontario – Canada-based Manufacturers Life Insurance Company The has invested 0% in Female Health Co (NASDAQ:FHCO). Gsa Partners Limited Liability Partnership owns 244,873 shares. Delta Asset Management Ltd Liability Corporation Tn reported 1,000 shares or 0% of all its holdings. Raymond James accumulated 23,075 shares or 0% of the stock. State Street holds 14,732 shares or 0% of its portfolio. Geode Cap Management Ltd Liability invested 0% of its portfolio in Female Health Co (NASDAQ:FHCO).
Since December 15, 2016, it had 3 buys, and 0 sales for $18,771 activity. Another trade for 7,931 shares valued at $8,139 was made by HAINES DANIEL on Wednesday, February 22. PARRISH O B bought $10,420 worth of stock. Another trade for 200 shares valued at $212 was bought by BETHUNE DAVID R.
The stock decreased 0.85% or $0.12 on March 21, reaching $13.96. About 3,477 shares traded. HUGO BOSS AG SPON ADR EA REPR 1 5 ORD (OTCMKTS:BOSSY) has risen 9.23% since August 15, 2016 and is uptrending. It has outperformed by 2.21% the S&P500.
